nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP2C9—cardial valve—dilated cardiomyopathy	0.0706	0.661	CbGeAlD
Guanfacine—Hypersomnia—Lisinopril—dilated cardiomyopathy	0.0432	0.0484	CcSEcCtD
Guanfacine—Cardiac fibrillation—Lisinopril—dilated cardiomyopathy	0.0432	0.0484	CcSEcCtD
Guanfacine—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.0254	0.0284	CcSEcCtD
Guanfacine—Leg pain—Lisinopril—dilated cardiomyopathy	0.0244	0.0274	CcSEcCtD
Guanfacine—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.0217	0.0243	CcSEcCtD
Guanfacine—Lethargy—Spironolactone—dilated cardiomyopathy	0.0205	0.0229	CcSEcCtD
Guanfacine—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.016	0.0179	CcSEcCtD
Guanfacine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0155	0.0173	CcSEcCtD
Guanfacine—NISCH—myocardium—dilated cardiomyopathy	0.0149	0.139	CbGeAlD
Guanfacine—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.0138	0.0155	CcSEcCtD
Guanfacine—Alopecia—Spironolactone—dilated cardiomyopathy	0.0123	0.0137	CcSEcCtD
Guanfacine—Vascular purpura—Furosemide—dilated cardiomyopathy	0.0122	0.0137	CcSEcCtD
Guanfacine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.0116	0.013	CcSEcCtD
Guanfacine—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.0116	0.013	CcSEcCtD
Guanfacine—Purpura—Furosemide—dilated cardiomyopathy	0.0113	0.0127	CcSEcCtD
Guanfacine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.0112	0.0126	CcSEcCtD
Guanfacine—Lethargy—Furosemide—dilated cardiomyopathy	0.0111	0.0125	CcSEcCtD
Guanfacine—Malaise—Spironolactone—dilated cardiomyopathy	0.0109	0.0122	CcSEcCtD
Guanfacine—Irritability—Furosemide—dilated cardiomyopathy	0.0104	0.0117	CcSEcCtD
Guanfacine—NISCH—heart—dilated cardiomyopathy	0.0104	0.0971	CbGeAlD
Guanfacine—Discomfort—Spironolactone—dilated cardiomyopathy	0.0102	0.0114	CcSEcCtD
Guanfacine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00997	0.0112	CcSEcCtD
Guanfacine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00994	0.0111	CcSEcCtD
Guanfacine—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00887	0.00993	CcSEcCtD
Guanfacine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00877	0.00982	CcSEcCtD
Guanfacine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00872	0.00976	CcSEcCtD
Guanfacine—Drowsiness—Furosemide—dilated cardiomyopathy	0.00841	0.00942	CcSEcCtD
Guanfacine—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00836	0.00936	CcSEcCtD
Guanfacine—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00819	0.00917	CcSEcCtD
Guanfacine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00813	0.0091	CcSEcCtD
Guanfacine—Sweating—Furosemide—dilated cardiomyopathy	0.00807	0.00903	CcSEcCtD
Guanfacine—Irritability—Lisinopril—dilated cardiomyopathy	0.00782	0.00875	CcSEcCtD
Guanfacine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00748	0.00838	CcSEcCtD
Guanfacine—Visual impairment—Furosemide—dilated cardiomyopathy	0.00728	0.00815	CcSEcCtD
Guanfacine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00727	0.00813	CcSEcCtD
Guanfacine—Asthma—Lisinopril—dilated cardiomyopathy	0.00708	0.00793	CcSEcCtD
Guanfacine—Eye disorder—Furosemide—dilated cardiomyopathy	0.00706	0.0079	CcSEcCtD
Guanfacine—Tinnitus—Furosemide—dilated cardiomyopathy	0.00704	0.00788	CcSEcCtD
Guanfacine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00698	0.00781	CcSEcCtD
Guanfacine—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00682	0.00764	CcSEcCtD
Guanfacine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00675	0.00755	CcSEcCtD
Guanfacine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00652	0.0073	CcSEcCtD
Guanfacine—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00652	0.0073	CcSEcCtD
Guanfacine—Weight increased—Lisinopril—dilated cardiomyopathy	0.00644	0.00721	CcSEcCtD
Guanfacine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00644	0.00721	CcSEcCtD
Guanfacine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00632	0.00708	CcSEcCtD
Guanfacine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00627	0.00702	CcSEcCtD
Guanfacine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00622	0.00697	CcSEcCtD
Guanfacine—Rash—Spironolactone—dilated cardiomyopathy	0.00622	0.00696	CcSEcCtD
Guanfacine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00621	0.00696	CcSEcCtD
Guanfacine—Vision blurred—Furosemide—dilated cardiomyopathy	0.0062	0.00694	CcSEcCtD
Guanfacine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00619	0.00693	CcSEcCtD
Guanfacine—Headache—Spironolactone—dilated cardiomyopathy	0.00618	0.00692	CcSEcCtD
Guanfacine—Sweating—Lisinopril—dilated cardiomyopathy	0.00605	0.00677	CcSEcCtD
Guanfacine—Agitation—Furosemide—dilated cardiomyopathy	0.00604	0.00676	CcSEcCtD
Guanfacine—Vertigo—Furosemide—dilated cardiomyopathy	0.00591	0.00661	CcSEcCtD
Guanfacine—Nausea—Spironolactone—dilated cardiomyopathy	0.00586	0.00656	CcSEcCtD
Guanfacine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00577	0.00646	CcSEcCtD
Guanfacine—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00568	0.00636	CcSEcCtD
Guanfacine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00564	0.00631	CcSEcCtD
Guanfacine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00547	0.00613	CcSEcCtD
Guanfacine—Confusional state—Furosemide—dilated cardiomyopathy	0.00541	0.00606	CcSEcCtD
Guanfacine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00528	0.00591	CcSEcCtD
Guanfacine—Shock—Furosemide—dilated cardiomyopathy	0.00528	0.00591	CcSEcCtD
Guanfacine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00519	0.00581	CcSEcCtD
Guanfacine—Hypotension—Furosemide—dilated cardiomyopathy	0.00501	0.00561	CcSEcCtD
Guanfacine—Alopecia—Lisinopril—dilated cardiomyopathy	0.00501	0.00561	CcSEcCtD
Guanfacine—Tension—Lisinopril—dilated cardiomyopathy	0.00484	0.00542	CcSEcCtD
Guanfacine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00483	0.00541	CcSEcCtD
Guanfacine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00482	0.00539	CcSEcCtD
Guanfacine—Nervousness—Lisinopril—dilated cardiomyopathy	0.00479	0.00536	CcSEcCtD
Guanfacine—Somnolence—Furosemide—dilated cardiomyopathy	0.00477	0.00534	CcSEcCtD
Guanfacine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00474	0.00531	CcSEcCtD
Guanfacine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00466	0.00522	CcSEcCtD
Guanfacine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00465	0.0052	CcSEcCtD
Guanfacine—Fatigue—Furosemide—dilated cardiomyopathy	0.00463	0.00518	CcSEcCtD
Guanfacine—Tremor—Lisinopril—dilated cardiomyopathy	0.00462	0.00517	CcSEcCtD
Guanfacine—Constipation—Furosemide—dilated cardiomyopathy	0.00459	0.00514	CcSEcCtD
Guanfacine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00458	0.00512	CcSEcCtD
Guanfacine—Malaise—Lisinopril—dilated cardiomyopathy	0.00445	0.00498	CcSEcCtD
Guanfacine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00443	0.00496	CcSEcCtD
Guanfacine—Syncope—Lisinopril—dilated cardiomyopathy	0.00442	0.00495	CcSEcCtD
Guanfacine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00442	0.00495	CcSEcCtD
Guanfacine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00439	0.00491	CcSEcCtD
Guanfacine—Palpitations—Lisinopril—dilated cardiomyopathy	0.00436	0.00488	CcSEcCtD
Guanfacine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00434	0.00485	CcSEcCtD
Guanfacine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00424	0.00475	CcSEcCtD
Guanfacine—Chest pain—Lisinopril—dilated cardiomyopathy	0.0042	0.0047	CcSEcCtD
Guanfacine—Myalgia—Lisinopril—dilated cardiomyopathy	0.0042	0.0047	CcSEcCtD
Guanfacine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.0042	0.0047	CcSEcCtD
Guanfacine—Anxiety—Lisinopril—dilated cardiomyopathy	0.00419	0.00469	CcSEcCtD
Guanfacine—Discomfort—Lisinopril—dilated cardiomyopathy	0.00415	0.00465	CcSEcCtD
Guanfacine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00411	0.0046	CcSEcCtD
Guanfacine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00406	0.00454	CcSEcCtD
Guanfacine—Oedema—Lisinopril—dilated cardiomyopathy	0.00403	0.00451	CcSEcCtD
Guanfacine—Shock—Lisinopril—dilated cardiomyopathy	0.00396	0.00443	CcSEcCtD
Guanfacine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00395	0.00443	CcSEcCtD
Guanfacine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00393	0.0044	CcSEcCtD
Guanfacine—CYP2C9—heart—dilated cardiomyopathy	0.0039	0.0365	CbGeAlD
Guanfacine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00389	0.00436	CcSEcCtD
Guanfacine—Asthenia—Furosemide—dilated cardiomyopathy	0.00385	0.00431	CcSEcCtD
Guanfacine—Pruritus—Furosemide—dilated cardiomyopathy	0.0038	0.00425	CcSEcCtD
Guanfacine—ADRA2A—heart—dilated cardiomyopathy	0.00378	0.0354	CbGeAlD
Guanfacine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00376	0.00421	CcSEcCtD
Guanfacine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00367	0.00411	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00367	0.00411	CcSEcCtD
Guanfacine—Insomnia—Lisinopril—dilated cardiomyopathy	0.00364	0.00408	CcSEcCtD
Guanfacine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00362	0.00405	CcSEcCtD
Guanfacine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00359	0.00402	CcSEcCtD
Guanfacine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00358	0.00401	CcSEcCtD
Guanfacine—Dizziness—Furosemide—dilated cardiomyopathy	0.00355	0.00397	CcSEcCtD
Guanfacine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00354	0.00397	CcSEcCtD
Guanfacine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.0035	0.00392	CcSEcCtD
Guanfacine—Fatigue—Lisinopril—dilated cardiomyopathy	0.00347	0.00389	CcSEcCtD
Guanfacine—Constipation—Lisinopril—dilated cardiomyopathy	0.00344	0.00385	CcSEcCtD
Guanfacine—Vomiting—Furosemide—dilated cardiomyopathy	0.00341	0.00382	CcSEcCtD
Guanfacine—Rash—Furosemide—dilated cardiomyopathy	0.00338	0.00379	CcSEcCtD
Guanfacine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00338	0.00378	CcSEcCtD
Guanfacine—Headache—Furosemide—dilated cardiomyopathy	0.00336	0.00376	CcSEcCtD
Guanfacine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00332	0.00371	CcSEcCtD
Guanfacine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00329	0.00369	CcSEcCtD
Guanfacine—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.00323	0.0303	CbGeAlD
Guanfacine—Nausea—Furosemide—dilated cardiomyopathy	0.00319	0.00357	CcSEcCtD
Guanfacine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00318	0.00356	CcSEcCtD
Guanfacine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00297	0.00332	CcSEcCtD
Guanfacine—Asthenia—Lisinopril—dilated cardiomyopathy	0.00289	0.00323	CcSEcCtD
Guanfacine—Pruritus—Lisinopril—dilated cardiomyopathy	0.00285	0.00319	CcSEcCtD
Guanfacine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00275	0.00308	CcSEcCtD
Guanfacine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00266	0.00298	CcSEcCtD
Guanfacine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00256	0.00287	CcSEcCtD
Guanfacine—Rash—Lisinopril—dilated cardiomyopathy	0.00254	0.00284	CcSEcCtD
Guanfacine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00254	0.00284	CcSEcCtD
Guanfacine—Headache—Lisinopril—dilated cardiomyopathy	0.00252	0.00282	CcSEcCtD
Guanfacine—Nausea—Lisinopril—dilated cardiomyopathy	0.00239	0.00268	CcSEcCtD
